Publications

5674 Results

Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 randomized neoadjuvant trial of weekly nab-paclitaxel with or without bevacizumab and dose dense doxorubicin and cyclophosphamide

Authors
X Li;S Warren;V Pelekanou;V Wali;M Liu;P Danaher;W Barlow;Z Nahleh;C Hatzis;L Pusztai
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 578); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Breast
Study Number(s)
S0800

Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)

Authors
K Crew;G Anderson;D Hershman;MB Terry;D Lew;M Yee;EA Brown;S Kairouz;L Minasian;L Ford;B Arun;M Neuhouser;P Brown
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 1550); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0812

SWOG S0905: A randomized Phase II Study of Cediranib versus Placebo in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Malignant Pleural Mesothelioma

Authors
A Tsao;J Miao;I Wistuba;N Vogelzang;J Heymach;F Fossella;C Lu;M Velasco;B Box-Noriega;J Hueftle;S Gadgeel;M Redman;D Gandara;K Kelly
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 8514); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), submitted 2/13/18; poster discussion
Year
2018
Research Committee(s)
Lung
Study Number(s)
S0905

Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927)

Authors
S Shen;JM Unger;K Crew;C Till;H Greenlee;J Gralow;S Dakhil;L Minasian;JL Wade;M Fisch;NL Henry;D Hershman
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 10000); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), submitted 2/13/18; accepted oral
Year
2018
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S0927

Prevalence of HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Among Newly Diagnosed Cancer Patients Treated in Academic and Community Oncology Practices

Authors
S Ramsey;J Unger;L Baker;R Little;R Loomba;J Hwang;R Chugh;M Konerman;K Arnold;D Hershman
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 6600); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1204

Standard vs High-dose Carfilzomib (Cfz) with Dexamethasone (Dex) for Relapsed/Refractory Multiple Myeloma (RRMM): Results of S1304, An Intergroup Study

Authors
S Ailawadhi;R Sexton;S Lentzsch;M Abidi;P Voorhees;AD Cohen;EM Rohren;S Heitner;K Kelly;N Mackler;D Baer;A Hoering;B Durie;R Orlowski
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 8015); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster discussion
Year
2018
Research Committee(s)
Myeloma
Study Number(s)
S1304

First comprehensive report of impact of genomic alterations, chemotherapy, targeted therapy and immunotherapy on outcomes in the genomics driven squamous master protocol LungMAP

Authors
V Papadimitrakopoulou;M Redman;D Gandara;F Hirsch;P Mack;C Langer;M Edelman;C Aggarwal;M Socinski;S Gettinger;SN Waqar;K Griffin;N Leighl;T Owonikoko;JD Bradley;S Ramalingam;T Stinchcombe;C Blanke;K Kelly;R Herbst
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 9019); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster discussion, abst. 9019
Year
2018
Research Committee(s)
Lung
Study Number(s)
S1400

Prevalence and prognosis of DNA repair deficiency in squamous cell carcinoma (SCC) patients enrolled on the S1400 LungMAP study

Authors
T Owonikoko;M Redman;L Byers;K Griffin;F Hirsch;P Mack;D Gandara;JD Bradley;T Stinchcombe;K Kelly;S Ramalingam;R Herbst;V Papadimitrakopoulou
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 9055); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster 9055
Year
2018
Research Committee(s)
Lung
Study Number(s)
S1400, S1400G

SWOG S1505: A Randomized Phase II Study of Perioperative mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma

Authors
D Sohal;S McDonough;S Ahmad;N Gandhi;MS Beg;A Wang-Gillam;K Guthrie;A Lowy;P Philip;H Hochster
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr TPS4153); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Gastrointestinal
Study Number(s)
S1505

SWOG S1512: A phase II and pilot trial of PD-1 blockade with pembrolizumab in patients with resectable or unresectable desmoplastic melanoma (DM)

Authors
K Kendra;J Moon;S Hu-Lieskovan;W Carson;D Campos;A Cochran;A Ribas
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr TPS9608)ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Melanoma
Study Number(s)
S1512